Navigation Links
New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma
Date:5/30/2008

Gene Expression Profiling of Tumor is Correlated With Clinical Response

CHICAGO, May 30 /PRNewswire-FirstCall/ -- New data presented by GlaxoSmithKline (GSK) today highlighted the potential of its investigational MAGE-A3 Antigen-Specific Cancer Immunotherapeutic (ASCI) through results of three studies evaluating highly targeted immunotherapy as a treatment for metastatic melanoma and non-small cell lung cancer (NSCLC). These data were presented at the 2008 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago (Abstract Nos: 9065(1), 9045(2) and 7501(3)).

A randomized, open label Phase II study designed to evaluate two different formulations of the MAGE-A3 ASCI in patients with metastatic melanoma has been conducted. In this study, the ASCI, which is a combination of MAGE-A3 recombinant protein and a GSK proprietary Adjuvant System, was evaluated and resultant data suggest a positive trend for clinical response. These data also demonstrate the induction of a desirable immune response, including humoral and cellular responses. These study results represent a second positive trend for clinical activity for the novel MAGE-A3 cancer immunotherapeutic, following encouraging clinical results reported in a separate double-blind, placebo-controlled Phase II study of patients with NSCLC(4). The encouraging results from the Phase II NSCLC study have led to a Phase III safety and efficacy trial in MAGE-A3-positive NSCLC patients (stage IB, II and IIIA) who have undergone complete surgical resection (MAGRIT; MAGE-A3 Adjuvant Non-Small Cell LunG CanceR ImmunoTherapy).

At this year's ASCO, GSK also presented data regarding the use of the genetic profiling of melanoma in predicting clinical outcomes of treatment with MAGE-A3 ASCI. Biopsies performed on the melanoma tumors prior to immunization were used to identify genetic markers expressed by the disease. These markers enabled researchers to establish a correlation between the expression
'/>"/>

SOURCE GlaxoSmithKline (GSK)
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Presentation of Data on Progens Cancer Epigenetic Targets Platform
2. Genmab Announces Updates on Phase III Cancer Studies
3. Access Pharmaceuticals Presents Favorable Ovarian Cancer Data and Clinical Update on ProLindac(TM) Development at Prestigious International Symposium
4. Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress
5. BiPar Sciences Expands Clinical Development of BSI-201, A Novel PARP Inhibitor, With Phase 2 Trial in Uterine Cancer
6. Prostate Cancer Treatment Offers Results Without Side Effects
7. TARGETED GENE DELIVERY SIGNALS CANCER VACCINATION IN VIVO: Intravenous Infusions of Rexin-G Followed by Reximmune-C Induce Tumor Necrosis and Recruitment of Tumor Infiltrating Lymphocytes in Cancerous Lesions (ASCO 2008)
8. First Patient Enrolled in Global Phase III Study of Bevacizumab and Trastuzumab in Early Breast Cancer
9. Node-Negative Early Stage Breast Cancer Patients Benefit from Taxotere(R)-Based Chemotherapy
10. Exiqon Forms Research Collaboration With M. D. Anderson Cancer Center
11. Ovarian Cancer Vaccine Clinical Trial Begins at Cancer Treatment Centers of America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... , July 21, 2014  AVT, Inc. (OTC ... automated retailing, micro-stores, custom vending machines and kiosks, ... automated medicine dispensing systems, which can be used ... and marijuana dispensaries. AVT,s newly designed systems provide ... medicines and regulated products. "We are ...
(Date:7/21/2014)... July 21, 2014   Aventura , the leader ... announced today that MemorialCare Health System , ... computing solution at the Orange Coast Memorial ... Orange Coast Memorial is a 218-bed ... 12,000 patients annually. The Aventura Roaming Aware Desktop ...
(Date:7/21/2014)... July 21, 2014   Regulus Therapeutics Inc ... leading the discovery and development of innovative medicines ... & Drug Administration (FDA) has granted orphan drug ... oligonucleotide that binds to and inhibits the function ... treatment of Alport syndrome, a life-threatening genetic kidney ...
Breaking Medicine Technology:Technology Driving Cannabis Industry 2MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 2MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 3MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 4Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 2Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 3Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 4Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 5
... Recession-driven budget cuts by hospitals and governmental entities reduced sales ... throughout fiscal 2010.  The company managed to offset much of ...  Still, the company reported a loss for the year. ... Allied sales fell about $6 million, or more than 11.7 ...
... ATLANTA and NEW YORK, Aug. 30 Inc. ... 2230 on its fourth annual Inc. 5000 list, an ... list represents the most comprehensive look at the most ... Music website Pandora, convenience store chain 7-Eleven, Brooklyn Brewery, ...
Cached Medicine Technology:Recession Leads to Sales Decline and Loss for Allied Healthcare Products in Fiscal 2010 2Recession Leads to Sales Decline and Loss for Allied Healthcare Products in Fiscal 2010 3Recession Leads to Sales Decline and Loss for Allied Healthcare Products in Fiscal 2010 4Recession Leads to Sales Decline and Loss for Allied Healthcare Products in Fiscal 2010 5West Physics Consulting Lands on the 2010 Inc. 5000 List 2West Physics Consulting Lands on the 2010 Inc. 5000 List 3
(Date:7/22/2014)... 22, 2014 For the past nine ... have been working in tandem to help thousands of ... access to care, and help survivors connect to resources ... foundations expanded their partnership to include referrals from PAF ... with the other practical, emotional, and financial issues that ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Get ... the Immune Deficiency Foundation (IDF) to provide ... portal that will allow them to electronically track their ... manage their illnesses. It will also allow those patients ... to consent to have their data shared with ...
(Date:7/22/2014)... Atreo Services will be presenting its full range ... accessories in booth #1423 at the American Society for ... Chicago, Ill., Aug. 3-6. , Atreo will display its ... well as its selection of liners and inserts designed ... In addition, representatives will be available to talk about ...
(Date:7/22/2014)... 2014 Altec Products, Inc. , ... announced today their Gold Sponsorship of Sage Summit ... Bay Hotel and Casino in Las Vegas, Nevada. The ... thousands interested in taking advantage of the many opportunities ... business problems and educate themselves on the latest enterprise ...
(Date:7/22/2014)... CA (PRWEB) July 22, 2014 Dr. ... to announce the launch of a new website dedicated ... The website can be found at DrKamrava.com . ... provide patients with a knowledgeable and trustworthy source for ... they suffer from hemorrhoids, fissures, gallstones, colon cancer, hernias, ...
Breaking Medicine News(10 mins):Health News:LIVESTRONG Foundation and Patient Advocate Foundation Expand Partnership to Support the Needs of Cancer Patients and Survivors Nationwide 2Health News:LIVESTRONG Foundation and Patient Advocate Foundation Expand Partnership to Support the Needs of Cancer Patients and Survivors Nationwide 3Health News:Get Real Health to Partner with Immune Deficiency Foundation 2Health News:Get Real Health to Partner with Immune Deficiency Foundation 3Health News:Atreo Services to Introduce Pneumatic Tube System Solutions at ASHE Annual Conference 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 3Health News:Los Angeles Doctor Launches Brand New Website for Colorectal Surgery and Treatment 2Health News:Los Angeles Doctor Launches Brand New Website for Colorectal Surgery and Treatment 3
... Texas, M. D. Anderson Cancer Center, John Mendelsohn, has been ... . This announcement was made in Paris, for his path ... Foundation which is located at the Tel Aviv University distributed ... million each to laureates chosen in areas where the contribution ...
... be the reason why isolated women are less vulnerable to falling ... ,The study is an eye-opener to the upcoming proof ... holds a clue to the reason why socially isolated men are ... studies have shown a connection between stress and immune function. But ...
... fall flat on its face, unless the government takes a leading ... local level work is going on in good measure, governments need ... area. The public Health Minister, Caroline Flint has confirmed the measures ... has sent the NHS expenditure sky rocketing almost ?1bn a year ...
... School of Public Health are one of the 14 ... Environmental Health Sciences// (NIEHS) to study the association between ... is a new study to control the rising obesity ... an individual’s body size. Working with various city departments, ...
... by Thomas Arcury, Ph.D., lead researcher, from Wake Forest University ... Carolina// widely use folk or home remedies, such as taking ... use is largely limited to home remedies, vitamins and minerals. ... more about what complementary and alternative medicine (CAM) therapies older ...
... to allegations that a perceived problem with the computer system ... schedule of thousands of babies and young children. ... initiative by the Government, to track the immunization schedule of ... that nearly 3,000 children would find themselves in the throes ...
Cached Medicine News:Health News:Women Portray Stronger Immune Response As Compared to Men, Study Suggests 2Health News:Inclination of North Carolina’s Elderly Population towards Home Remedie 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: